GlaxoSmithKline Pakistan Limited (GLAXO)

Shariah Disclosure for the Half Year ended June 30, 2026

Live Market Price

PKR 319.39

-6.62 (-2.03%)

AI Financial Summary & Key Takeaways

Automated extraction from official regulatory filing

Analyzed Sep 15, 07:45 AM

GLAXO filed Shariah compliance disclosure for the half-year ended June 30, 2026.

This filing confirms adherence to Shariah principles for the specified reporting period.

No immediate financial impact; review full document for detailed compliance metrics.

Official company disclosure filed on Pakistan Stock Exchange

Document link not provided

Share this announcement with fellow investors:

Receive real-time WhatsApp & Android push notifications whenever GLAXO announces board meetings, dividend payouts, or moves in price.

Transmission of Quarterly Report for the Period Ended September 30, 2026

Financial Results for the Quarter Ended September 30, 2026

Board Meeting Quarter 3-2026

Credit of Interim Cash Dividend

Appointment of Chief Financial Officer

Appointment of Executive Director